Bijan Nejadnik
Company: Mitsubishi Tanabe Pharma
Job title: Head of Global Development, Regulatory Affairs & Quality Assurance
Seminars:
Panel Discussion: Striving for Consensus on the Level of Evidence Required for Approval 10:45 am
How can we best reconcile the variance in acceptable measures of ALSFRS-R decline across geographies to get drugs to patients faster? How translatable is success of accelerated approval in familial ALS to sporadic ALS? When are expanded access programs deemed acceptable ahead of final study results? If there’s going to be a move towards accelerated…Read more
day: Day Two Track B AM